Exabis Library
Welcome to the e-CCO Library!
P214: Plasma fatty acid binding protein 2, interleukin-10 and lipopolysaccharides as biomarkers for microscopic colitis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P214: What is the diagnostic accuracy of faecal calprotectin regarding endoscopic relapse in Crohn's disease patients following ileocecal resection? A tertiary single center experience
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P215 The effect of resection margin involvement of Crohn’s disease on the surgical and clinical recurrence after intestinal surgery
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P215: Blood-based prognostic biomarkers in Crohn’s patients treated with biologics: a new promising tool to predict endoscopic outcomes
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P215: Clinical features of chronic enteropathy associated with SLCO2A1 gene (CEAS)
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P215: Correlation between small bowel capsule endoscopy and biomarkers in postoperative recurrence in Crohn’s Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P215: Deep immune phenotyping of unconventional T cells reveals a depletion in Mucosa Associated T Cells (MAIT) in IBD patients with extraintestinal manifestations
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P215: The determination of anti-saccharomyces cerevisiae antibodies at diagnosis of Crohn’s disease allows selecting a group of patients with higher risk of developing a complicated behaviour: A prospective study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P215: The influence of disease activity on birth outcomes in patients with inflammatory bowel disease: Meta- analysis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P215: The mean platelet volume compared with other serum biomarkers: is it predictive of activity of Crohn’s disease?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P216 Anti-drug antibodies to infliximab: A comparison of free anti-drug antibody measurement
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P216: Comparative Assessment C-reactive Protein Between a Point-of-Care Testing and Current Standard of Care (Immunonephelometric testing)
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P216: Does mucosal inflammation drive recurrence of PSC in liver transplant recipients with ulcerative colitis?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P216: Effect of the Crohn’s disease exclusion diet (CDED) on the fecal calprotectin level in children with active Crohn’s disease.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P216: Impact of disease knowledge on quality of life of inflammatory bowel disease patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P216: Mesenteric disease is directly related to mucosal disease in Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P216: Natural course of inflammatory bowel disease in a Turkish cohort: a single tertiary centre experience in Ankara (2006–2015)
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P216: Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocecal resection for Crohn's disease: a retrospective analysis of 853 consecutive patients treated in a tertiary centre.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P217 The role of 7-alfa-hydroxy-4-cholesten-3-one (C4) as a biomarker for bile acid malabsorption in inflammatory bowel disease and microscopic colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P217: Clostridium Difficile Infection as a cause of severe outcomes in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM